case_images: PMC6057401_01
case_images: Area of hypercellular bone marrow with red cell aplasia.
case_images: CRIHEM2018-6928571.001.jpg
case_images: PMC6057401_01_CRIHEM2018-6928571.001.jpg
case_images: fig1
case_images: Erythropoiesis was markedly decreased with only very rare proerythroblasts present (Figure 1).
case_images: Bone marrow with hypercellularity and increased mast cells.
case_images: CRIHEM2018-6928571.002.jpg
case_images: PMC6057401_01_CRIHEM2018-6928571.002.jpg
case_images: fig2
case_images: Several perivascular fibrotic areas containing mast cell aggregates were also identified (Figures 2 and 3).
case_images: Clot section which shows hypercellularity and increased mast cells.
case_images: CRIHEM2018-6928571.003.jpg
case_images: PMC6057401_01_CRIHEM2018-6928571.003.jpg
case_images: fig3
case_images: Several perivascular fibrotic areas containing mast cell aggregates were also identified (Figures 2 and 3).
case_images: Clot stained with CD2 which is positive in mast cells.
case_images: CRIHEM2018-6928571.004.jpg
case_images: PMC6057401_01_CRIHEM2018-6928571.004.jpg
case_images: fig4
case_images: The mast cells were positive for mast cell tryptase and aberrant expression of CD2 and CD25 (Figures 4 and 5). c-KIT and D 816 V mutations were detected.
case_images: Clot stained with CD25 which is positive in mast cells.
case_images: CRIHEM2018-6928571.005.jpg
case_images: PMC6057401_01_CRIHEM2018-6928571.005.jpg
case_images: fig5
case_images: The mast cells were positive for mast cell tryptase and aberrant expression of CD2 and CD25 (Figures 4 and 5). c-KIT and D 816 V mutations were detected.